Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor. - Wikidata - wikimedia - TriplyDB

Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.

Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.

http://www.wikidata.org/entity/Q34450749

about

ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphoma Anaplastic lymphoma kinase: signalling in development and disease Inhibitors of the anaplastic lymphoma kinase ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions.Molecular strategies for detecting chromosomal translocations in soft tissue tumors (review).An Unusual Case of Systemic Inflammatory Myofibroblastic Tumor with Successful Treatment with ALK-Inhibitor KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only Oral inflammatory myofibroblastic tumor: case report and review of literature Epithelioid inflammatory myofibroblastic sarcoma in abdominal cavity: a case report and review of literature.ALK-immunoreactive neoplasms.Current management of pediatric soft tissue sarcomas.SEC31A-ALK Fusion Gene in Lung Adenocarcinoma.Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes ALK gene amplification is associated with poor prognosis in colorectal carcinoma Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report Oncogenic mutations of ALK in neuroblastoma.Gastrointestinal Mesenchymal Neoplasms other than Gastrointestinal Stromal Tumors: Focusing on Their Molecular Aspects.Targeted therapies for sarcomas: new roles for the pathologist.ALK-positive cancer: still a growing entity.Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas.Detecting and targetting oncogenic fusion proteins in the genomic era.Novel ALK inhibitors in clinical use and development.Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum.Targeting ALK: Precision Medicine Takes on Drug Resistance.The role of anaplastic lymphoma kinase in pediatric cancers.Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies.Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcoma NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases.A malignant inflammatory myofibroblastic tumor of the hypopharynx harboring the 3a/b variants of the EML4-ALK fusion gene.Cytogenetically complex SEC31A-ALK fusions are recurrent in ALK-positive large B-cell lymphomas The Scandinavian Sarcoma Group: 30 years' experience.Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes.Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors.Anaplastic lymphoma kinase (ALK) gene alteration in gastric signet ring cell carcinoma.Patterns of ALK expression in different human cancer types.Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in-situ hybridization for the detection of anaplastic lymphoma kinase alterations.

P2860

Q21129306-8B591B74-CC4E-4A2B-B2D8-A57615DF3CD3 Q21285042-BF7810A7-DEC6-46AF-A815-5E0AC3E8BFED Q24312329-16A9AC43-A44B-434D-B35C-F979C154380B Q28267124-2D6184C8-18B9-4EAA-8EDA-FDAC0B0C0E27 Q33707493-9F942595-979A-4664-BD00-35CAE8A71F5A Q33747747-2E6C436F-D02B-4553-8AB1-ED05D1F7B297 Q33865631-3C57F60F-3B62-43B6-A9C2-70F7144C6A92 Q34162787-F016226F-4FC8-447B-812C-40EB151D5209 Q34964264-4E180437-39BA-40C9-ACC1-68D5E88AFC7E Q35741228-135441C9-305B-4358-809A-976701C10C81 Q36092957-C7859571-6E30-4914-A303-1EAADD113CD0 Q36262280-DB9E89BB-5AAA-4DB9-9336-0BD4D52C492D Q36482476-157D11EE-4A7B-4D23-9B25-46F43ED009AC Q37129515-695410EB-2D93-40A1-9E24-54F8489207F5 Q37234080-C337F84C-7321-4FA6-9EC3-F7DF59AD409C Q37323062-12D5C956-28A0-4A8D-B12A-F79B7C0E8A2C Q37411178-C2CDD501-7D27-4E0C-91CA-18B6B7E5C63C Q37417034-E0F1D319-92AB-486A-8421-9A6CF973E08D Q37825940-FBA06F80-94F9-41C5-8BF8-34F2273AA4F5 Q37853030-11FC437E-266A-47FD-AB07-29D638BF9ECE Q38151788-CD739BDF-2A6A-4B0A-977C-2C7D55C652B6 Q38184584-2961EB64-CA23-4C9B-A9B6-4E96ABB5923A Q38307616-E200396E-E10D-4461-B7DA-27FBE1FCD078 Q38336067-A338E479-8D48-46BB-B3CA-E7C5A02786F8 Q38427240-E3298014-DB77-49B6-9AE6-90E4A7B340A6 Q38700674-8B28F30E-4377-4DBE-A25F-E5230E571D09 Q39103431-B1917008-B7BB-4A12-8828-E5DDC33FAC1D Q41844175-082F32D2-2635-4B6B-B7DC-D07634140048 Q41942675-818A6188-6621-4560-9134-1B33DA070CC7 Q42181725-B7B21498-8BBC-4759-9725-2D79B9498D45 Q42254184-D5E1DB00-83BB-4774-AE78-3C4B830C1003 Q42316364-0352FA0B-DAA4-4EBB-8F69-4BF6B200FE06 Q42586803-B52B69B2-C70E-4446-BC03-AC485C5BD037 Q43589203-088A2326-D690-4597-B285-84F3088018B1 Q52679023-157D74E5-9139-409C-AB4D-D7609BB788B7 Q53637916-3673C4D8-2DAD-4264-9619-A84A52711A0C Q53692985-81076C96-2828-4B31-9462-2B8FCB3F8F4B Q54225340-80D7D7CE-3FF9-4AF5-BA63-2A4C02296A5E Q55070169-6D5DE6AC-7514-4922-87BC-9FF9BFB9B147

P2860

Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.

http://www.wikidata.org/entity/Q34450749

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.

@ast

Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.

@en

Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.

@nl

type

label

Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.

@ast

Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.

@en

Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.

@nl

prefLabel

Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.

@ast

Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.

@en

Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.

@nl

P1433

Q34450749-406D7872-5419-46BB-91BB-3CE075F440BF

P1476

Q34450749-CB10DF42-89A2-43EE-A4F1-E1EBE79BE202

P2093

Q34450749-0529BCCE-CB2C-446E-99C4-72FB77053C36

Q34450749-3D81D657-74E3-4633-B0D7-DBB7C0819A0F

Q34450749-8F243673-1F0E-4BA0-ADC6-E3023A470A96

Q34450749-D05B93B3-59AB-4FB6-8C6C-7AED0AD0A19D

Q34450749-E047472C-C622-4C24-A528-EE828E82D522

P2860

Q34450749-2431EE62-14A5-4542-A51B-5A3AF14B7849

Q34450749-293BB751-F8D3-4202-9E04-7325BD3481B3

Q34450749-3AA2E8FA-CA65-4633-BAD1-2148F3658797

Q34450749-403A56BE-F8CB-4850-8A91-EFA85939B551

Q34450749-53A94422-44A5-4B7A-B914-93F3E5B9C9D7

Q34450749-5759ACB4-240C-4A77-B633-FD63611F7382

Q34450749-63F965F9-0AF2-4B14-9E67-34761A129223

Q34450749-78D756C2-9886-404F-BE16-3DC9A982A8E6

Q34450749-8BAF4B71-F244-41A4-80C8-DE55095DFC6B

Q34450749-8E0EFBF9-2751-4190-89B7-06757989D48C

P304

Q34450749-7A46E3C7-D65E-4A7C-83ED-788CE8572BB6

P31

Q34450749-53445973-E9BF-4A51-8431-68E22945A0A5

P356

Q34450749-6A3A6035-83FB-43D8-A932-D969A7C7527F

P433

Q34450749-694F3203-8011-4DEC-AC7F-BB3DBBA86E36

P478

Q34450749-55D4EE94-4649-401C-B822-D079295E7842

P50

Q34450749-3C89A2FE-C7D3-44E3-BB5D-8C799E2105EE

Q34450749-5D5F8DEF-DAC2-4196-97A2-D8EBE6F02EB1

P577

Q34450749-F5F2B222-E0F9-4BDD-AD38-4E3D155B3D83

P5875

Q34450749-2D10E63D-E436-4C7C-86F4-5A6A41A89E8D

P698

Q34450749-57681A10-7323-48D1-B4C2-83CF35D4A247

P356

P1433

International Journal of Cancer

P1476

Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.

@en

P2093

Henryk A Domanski

http://www.w3.org/2001/XMLSchema#string

Margareth Isaksson

http://www.w3.org/2001/XMLSchema#string

Nils Mandahl

http://www.w3.org/2001/XMLSchema#string

Pia Lindblom

http://www.w3.org/2001/XMLSchema#string

Therese Nilsson

http://www.w3.org/2001/XMLSchema#string

P2860

Mammalian homologues of yeast sec31p. An ubiquitously expressed form is localized to endoplasmic reticulum (ER) exit sites and is essential for ER-Golgi transport

Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis

Clathrin-dependent endocytosis

TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors

The WD repeat: a common architecture for diverse functions

Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor

WD-repeat proteins: structure characteristics, biological function, and their involvement in human diseases

Inflammatory myofibroblastic tumor in children: diagnosis and treatment.

Translocations involving anaplastic lymphoma kinase (ALK).

P304

1181-1186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.21490

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Fredrik Mertens

Ioannis Panagopoulos

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7601997

http://www.w3.org/2001/XMLSchema#string

P698

16161041

http://www.w3.org/2001/XMLSchema#string